A single blood test was found to predict cardiovascular events in women over a 30-year period, according to a study published Aug. 31 in The New England Journal of Medicine.
Author: Elizabeth Gregerson
The European Society of Cardiology released four updated guidelines for management of various cardiovascular conditions at the ESC Congress 2024.
GLP-1s reduced mortality and complications from cardiovascular events, according to a study published Aug. 22 in Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics.
GLP-1s reduced mortality and complications from cardiovascular events, according to a study published Aug. 22 in Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics.
High-poverty rural regions in the Southern U.S. have the highest cardiovascular disease-associated death rate, according to a report published Aug. 16 in the Journal of Rural Health.
Advertisement
Catheter-based, radiofrequency renal denervation is a cost-effective solution for patients with hypertension, according to a study published Aug. 13 in the Journal of the Society for Cardiovascular Angiography & Interventions.
The FDA approved a label change for Abbott's HeartMate 3 heart pump, eliminating aspirin use from patient treatment plans.
Women with postoperative atrial fibrillation have a higher risk of mortality than men, according to a study published Aug. 21 in JAMA Network Open.
Leaders from four cardiology hospitals that were ranked among the best by U.S. News & World Report shared with Becker's what they would change about cardiology care.
From traveling to space to running for mayor, here are 12 cardiologists making headlines: